Journal of Inflammation Research,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 11375 - 11402
Published: Dec. 1, 2024
Systemic
lupus
erythematosus
is
a
heterogeneous
autoimmune
disease.
A
burst
of
reactions
in
various
systems
can
lead
to
severe
clinical
conditions
closely
associated
with
mortality.
T
cells
serve
as
mediators
that
drive
the
occurrence
and
maintenance
inflammatory
processes.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(2), P. 282 - 282
Published: Jan. 27, 2025
This
paper
explores
various
aspects
of
microbiology
and
immunology,
with
a
particular
focus
on
the
epidemiology
molecular
characterisation
infectious
diseases
in
Caribbean
South
America.
Key
areas
investigation
include
tuberculosis
(TB),
experimental
vaccines,
bloodborne
pathogens.
A
retrospective
study
conducted
Jamaica
highlights
significance
early
HIV
screening,
timely
diagnosis,
inte-grated
care.
The
also
examines
challenges
posed
by
nosocomial
infections,
particularly
those
caused
antibiotic-resistant
Gram-negative
bacteria
methicillin-resistant
Staphylococcus
aureus
(MRSA),
emphasising
critical
importance
infection
control
measures.
Additionally,
it
regional
microbiome,
global
response
to
diseases,
immune
responses
patients
immunodeficiency
disorders
such
as
severe
combined
(SCID)
chronic
granulomatous
disease
(CGD),
underscoring
their
heightened
susceptibility
wide
range
infections.
Diagnostics,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1186 - 1186
Published: June 5, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
chronic
autoimmune
condition
that
can
seriously
impair
multiple
organs
including
the
nervous
system,
causing
neuropsychiatric
SLE
(NPSLE),
which
encompasses
broad
range
of
symptoms.
Pathogenesis
not
completely
understood
but
thought
to
involve
inflammatory
and
vascular
pathways.
This
comprehensive
review
discusses
complex
nature
heterogeneity
NPSLE
challenges
in
diagnosis
treatment
result
from
it.
Diagnosis
often
requires
multidisciplinary
approach
with
assessments,
laboratory
testing,
imaging,
neuropsychological
evaluations.
Current
treatments
focus
on
managing
symptoms
through
immunosuppressive
anti-thrombotic
therapies
tailored
or
specific
manifestations.
paper
emphasizes
necessity
for
interdisciplinary
approaches
further
research
enhance
diagnostic
accuracy
effectiveness.
It
also
highlights
importance
understanding
underlying
mechanisms
develop
more
targeted
therapies,
citing
need
high-quality
studies
novel
agents.
World Journal of Psychiatry,
Journal Year:
2025,
Volume and Issue:
15(2)
Published: Jan. 14, 2025
BACKGROUND
Not
all
neuropsychiatric
(NP)
manifestations
in
patients
with
systemic
lupus
erythematosus
(SLE)
are
secondary
to
lupus.
The
clarification
of
the
cause
NP
symptoms
influences
therapeutic
strategies
for
SLE.
AIM
To
understand
attribution
psychiatric
a
cohort
Chinese
METHODS
This
retrospective
single-center
study
analyzed
160
inpatient
medical
records.
Clinical
diagnosis,
which
is
considered
gold
standard,
was
used
divide
subjects
into
SLE
(PSLE)
group
(G1)
and
(G2).
features
were
compared
between
these
two
groups.
sensitivity
specificity
Italian
model
explored.
RESULTS
A
total
171
syndromes
recorded
138
patients,
including
87
cases
acute
confusional
state,
40
cognitive
dysfunction,
18
psychosis,
13
each
depressive
disorder
mania
or
hypomania.
141
(82.5%)
attributed
In
contrast
G2
G1
had
higher
Disease
Activity
Index-2000
scores
(21
vs
12,
P
=
0.001),
lower
prevalence
anti-beta-2-glycoprotein
1
antibodies
(8.6%
25.9%,
0.036),
anti-ribosomal
ribonucleoprotein
particle
(rRNP)
(39.0%
22.2%,
0.045).
exhibited
95.0%
70.0%
when
threshold
value
set
at
7.
CONCLUSION
Patients
PSLE
increased
disease
activity.
There
correlation
anti-rRNP
antibodies.
effectively
assesses
multiple
who
present
symptoms.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 503 - 503
Published: Feb. 18, 2025
Background:
Fibromyalgia,
depression,
and
autoimmune
diseases
represent
a
triad
of
interconnected
conditions
characterized
by
overlapping
biological
pathways,
including
chronic
inflammation,
immune
dysregulation,
neurochemical
imbalances.
Understanding
their
shared
mechanisms
offers
opportunities
for
innovative
therapeutic
approaches.
Objective:
This
systematic
review
explores
the
common
inflammatory-
immune-related
pathways
among
these
conditions,
emphasizing
implications
biomarker
development
novel
strategies.
Methods:
Following
PRISMA
guidelines,
comprehensive
literature
search
was
conducted
in
databases
PubMed,
Scopus,
Web
Science,
Cochrane
Library.
Studies
examining
relationship
between
fibromyalgia,
with
focus
on
responses,
inflammatory
biomarkers,
interventions
were
included.
The
quality
selected
studies
assessed
using
Risk
Bias
tool.
Results:
From
255
identified
studies,
12
met
inclusion
criteria.
Evidence
supports
role
pro-inflammatory
cytokines
(e.g.,
IL-6,
TNF-α)
dysregulation
serotonin,
dopamine)
as
key
factors
pathophysiology
conditions.
Pilot
highlight
potential
immune-modulating
therapies,
low-dose
IL-2
anti-inflammatory
agents
such
N-acetylcysteine
minocycline,
alleviating
both
physical
psychological
symptoms.
Emerging
cytokine
profiles
platelet
serotonin
activity,
show
promise
personalized
treatment
Conclusions:
linking
underscore
need
integrated
Although
pilot
provide
preliminary
insights,
validation
through
large-scale,
multicenter
trials
is
essential.
Future
research
should
standardizing
methodologies
leveraging
biomarker-driven
precision
medicine
to
improve
outcomes
patients
complex,
multifactorial
Neuroglia,
Journal Year:
2025,
Volume and Issue:
6(1), P. 10 - 10
Published: March 1, 2025
Vestibular
disorders
significantly
affect
individuals
by
impairing
balance,
spatial
orientation,
and
quality
of
life.
Despite
the
focus
on
neuronal
mechanisms,
emerging
research
emphasizes
importance
neuroglia—astrocytes,
microglia,
oligodendrocytes,
Schwann
cells—in
onset,
progression,
resolution
these
conditions.
This
narrative
review
explores
roles
neuroglia
in
vestibular
disorders,
including
migraines
unilateral
bilateral
vestibulopathies.
It
discusses
established
facts,
challenges,
future
perspectives,
offering
insights
into
their
pathophysiological
therapeutic
implications,
limitations
current
research.
By
understanding
interplay
between
function,
this
aims
to
advance
diagnostic
treatment
strategies
for
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
This
systematic
review
comprehensively
analyzes
the
neurological
complications
associated
with
Sjögren's
Syndrome
(SS),
focusing
on
peripheral
neuropathy,
central
nervous
system
(CNS)
involvement,
cognitive
dysfunction,
and
autonomic
dysregulation.
Eight
studies,
published
between
2010
2024,
were
meticulously
selected,
encompassing
a
range
of
study
designs,
patient
populations,
diagnostic
methodologies.
The
findings
highlight
substantial
burden
manifestations
in
SS,
neuropathy
identified
as
most
prevalent
complication,
followed
by
impairment
CNS
vasculitis.
underscores
critical
need
for
standardized
criteria
outcome
measures
to
facilitate
early
detection
effective
intervention.
Although
some
studies
report
promising
results
regarding
efficacy
immunotherapy
other
therapeutic
approaches,
absence
randomized
controlled
trials
(RCTs)
significantly
hampers
ability
establish
definitive
treatment
guidelines.
Additionally,
this
highlights
importance
accounting
confounding
factors,
such
comorbid
conditions,
understanding
disease
progression
efficacy.
It
calls
further
research
investigate
innovative
options
develop
personalized
plans
tailored
specific
needs
SS
patients
complications.
Diagnostics,
Journal Year:
2025,
Volume and Issue:
15(7), P. 824 - 824
Published: March 25, 2025
Background:
Systemic
lupus
erythematosus
(SLE)
is
a
multisystem
autoimmune
disorder.
Neuropsychiatric
manifestations
are
frequently
observed
and
associated
with
increased
morbidity
reduced
quality
of
life.
Magnetic
resonance
imaging
(MRI)
the
neuroimaging
procedure
choice
for
investigation.
High-resolution
vessel
wall
(HRVWI)
methodology
that
allows
active
mapping
pathophysiological
processes
involving
brain
walls.
Methods:
To
exemplify
importance
HRVWI
its
usefulness
in
patients
SLE,
we
carried
out
scoping
review
(following
PRISMA
guidelines)
using
PubMed
Embase
databases.
Results:
We
retrieved
10
studies
utilized
neuropsychiatric
including
total
69
patients.
The
majority,
84%
(58/69),
were
women,
ages
ranging
between
16
80
years
(average
38.4
years).
Approximately
46.3%
(32/69)
had
white
matter
lesions
at
time
investigation,
77%
(53/69)
normal
magnetic
angiography.
Treatment
immunosuppressants
led
to
resolution
majority
findings.
Conclusions:
Imaging
plays
an
important
role
investigating
SLE.
analysis
gaining
more
importance,
ability
identify
inflammation
even
if
angiographic
MRI
sequences
(3D
TOF)
normal,
allowing
institution
early
immunosuppressant
treatment
symptoms.